Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Total Non-Current Liabilities: 2009-2025

Historic Total Non-Current Liabilities for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Sep 2025 value amounting to $546.3 million.

  • UNITED THERAPEUTICS's Total Non-Current Liabilities fell 37.45% to $546.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $546.3 million, marking a year-over-year decrease of 37.45%. This contributed to the annual value of $738.1 million for FY2024, which is 33.17% down from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Total Non-Current Liabilities of $546.3 million as of Q3 2025, which was up 3.64% from $527.1 million recorded in Q2 2025.
  • In the past 5 years, UNITED THERAPEUTICS's Total Non-Current Liabilities ranged from a high of $1.2 billion in Q3 2023 and a low of $527.1 million during Q2 2025.
  • Moreover, its 3-year median value for Total Non-Current Liabilities was $932.3 million (2024), whereas its average is $913.0 million.
  • Per our database at Business Quant, UNITED THERAPEUTICS's Total Non-Current Liabilities climbed by 11.49% in 2023 and then plummeted by 43.46% in 2025.
  • Over the past 5 years, UNITED THERAPEUTICS's Total Non-Current Liabilities (Quarterly) stood at $1.1 billion in 2021, then rose by 3.42% to $1.1 billion in 2022, then dropped by 3.39% to $1.1 billion in 2023, then tumbled by 33.17% to $738.1 million in 2024, then slumped by 37.45% to $546.3 million in 2025.
  • Its Total Non-Current Liabilities stands at $546.3 million for Q3 2025, versus $527.1 million for Q2 2025 and $721.5 million for Q1 2025.